title: The number of vitamin D receptor binding sites defines the different vitamin D responsiveness of the CYP24 gene in malignant and normal mammary cells.
abstract: Primary 1alpha,25-dihydroxyvitamin D(3) (1alpha,25(OH)(2)D(3))-responding genes are controlled by the vitamin D receptor (VDR) binding to specific sites (VDREs) that are located within the regulatory regions of these genes. According to previous studies, the gene encoding 25-dihydroxyvitamin D(3) 24-hydroxylase, CYP24, which is the strongest known 1alpha,25(OH)(2)D(3)-responsive gene, has multiple VDREs that locate within the proximal and the distal promoter. However, it has remained unclear, what is the biological role of these regions and how they participate in the regulation of transcription. In this study, we found a different CYP24 expression profile in normal (MCF-10A) and malignant (MCF-7) human mammary cells. Moreover, CYP24 mRNA showed to be three times more stable in MCF-7 cells than in MCF-10A cells. We studied the mechanism of this difference using expression profiling, quantitative chromatin immunoprecipitation and chromosome conformation capture assays. Interestingly, the number of functional VDREs was higher in MCF-7 cells than in MCF-10A cells. Three functional VDREs in MCF-7 cells are connected to linear mRNA accumulation, whereas only one VDRE seems to lead to stepwise CYP24 mRNA accumulation in MCF-10A cells. The distal VDREs were involved in transcriptional regulation via ligand-dependent, dynamic chromatin looping, which brings cyclically the distal elements together either individually or simultaneously next to the transcription start site. In conclusion, our data suggest that in comparison to normal cells, clearing of 1alpha,25(OH)(2)D(3) is enhanced in malignant cells due to differences in transcriptional regulation of CYP24 and metabolism of CYP24 mRNA.
authors.affiliation: Department of Biosciences, University of Eastern Finland, FIN-70211 Kuopio, Finland.
authors.forename: Juha M
authors.initials: JM
authors.lastname: Matilainen
authors.forename: Marjo
authors.initials: M
authors.lastname: Malinen
authors.forename: Mikko M
authors.initials: MM
authors.lastname: Turunen
authors.forename: Carsten
authors.initials: C
authors.lastname: Carlberg
authors.forename: Sami
authors.initials: S
authors.lastname: Väisänen
mesh_terms: D001940:Breast / Q000378:metabolism*; D001943:Breast Neoplasms / Q000378:metabolism*; D045744:Cell Line, Tumor; D002467:Cell Nucleus / Q000378:metabolism; D002843:Chromatin / Q000737:chemistry; D044127:Epigenesis, Genetic; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008024:Ligands; D011401:Promoter Regions, Genetic; D012333:RNA, Messenger / Q000378:metabolism; D018167:Receptors, Calcitriol / Q000378:metabolism*; D013250:Steroid Hydroxylases / Q000378:metabolism*; D013997:Time Factors; D014807:Vitamin D / Q000737:chemistry / Q000378:metabolism*; D065668:Vitamin D3 24-Hydroxylase
chemical_list: D002843:Chromatin; D008024:Ligands; D012333:RNA, Messenger; D018167:Receptors, Calcitriol; D014807:Vitamin D; D013250:Steroid Hydroxylases; D065668:Vitamin D3 24-Hydroxylase
references.citation: Annu Rev Immunol. 1991;9:373-98
references.pmid: 1910683
references.citation: Nucleic Acids Res. 2009 Jul;37(12):4135-48
references.pmid: 19433513
references.citation: J Cell Sci. 2001 Jul;114(Pt 13):2363-73
references.pmid: 11559745
references.citation: J Biol Chem. 2009 Mar 20;284(12):8073-82
references.pmid: 19122196
references.citation: J Steroid Biochem Mol Biol. 2006 Aug;100(4-5):184-92
references.pmid: 16828283
references.citation: Cell. 2006 Apr 21;125(2):301-13
references.pmid: 16630818
references.citation: Nature. 1995 Oct 5;377(6548):397-404
references.pmid: 7566114
references.citation: Oncogene. 2007 Nov 1;26(50):7153-7
references.pmid: 17486062
references.citation: Nature. 2006 May 18;441(7091):349-53
references.pmid: 16625203
references.citation: Nucleic Acids Res. 2007;35(8):2734-47
references.pmid: 17426122
references.citation: J Biol Chem. 2008 Nov 21;283(47):32977-88
references.pmid: 18728018
references.citation: Crit Rev Eukaryot Gene Expr. 1998;8(1):19-42
references.pmid: 9673449
references.citation: Mol Endocrinol. 2003 May;17(5):777-91
references.pmid: 12637589
references.citation: Ann Epidemiol. 2009 Jul;19(7):468-83
references.pmid: 19523595
references.citation: Curr Protoc Mol Biol. 2006 May;Chapter 21:Unit 21.11
references.pmid: 18265379
references.citation: Curr Opin Genet Dev. 1999 Apr;9(2):140-7
references.pmid: 10322133
references.citation: Pharmacogenetics. 1996 Feb;6(1):1-42
references.pmid: 8845856
references.citation: Cell. 2006 Jan 13;124(1):47-59
references.pmid: 16413481
references.citation: Nucleic Acids Res. 2005 Sep 26;33(17):5521-32
references.pmid: 16186133
references.citation: Mol Endocrinol. 2006 Jun;20(6):1231-47
references.pmid: 16497728
references.citation: Science. 2002 Mar 8;295(5561):1901-4
references.pmid: 11884757
references.citation: Cell. 2003 Dec 12;115(6):751-63
references.pmid: 14675539
references.citation: Trends Biochem Sci. 1995 Apr;20(4):143-6
references.pmid: 7770913
references.citation: Nature. 1995 Oct 5;377(6548):454-7
references.pmid: 7566127
references.citation: J Mol Biol. 2005 Jul 1;350(1):65-77
references.pmid: 15919092
references.citation: Nature. 2008 Mar 6;452(7183):45-50
references.pmid: 18322525
references.citation: Cell. 2009 Aug 7;138(3):489-501
references.pmid: 19665971
references.citation: Cell. 2007 May 18;129(4):823-37
references.pmid: 17512414
references.citation: Eur J Biochem. 1997 Aug 15;248(1):156-62
references.pmid: 9310373
references.citation: EMBO J. 1993 Nov;12(11):4279-90
references.pmid: 8223438
references.citation: Nat Genet. 2007 Mar;39(3):311-8
references.pmid: 17277777
references.citation: Biochem Cell Biol. 2005 Aug;83(4):418-28
references.pmid: 16094445